A recent study showed that patients with PIK3CA mutations had a higher rate of hemorrhage as the initial symptom of CCM diagnosis than those with only the MAP3K3 I441M mutation and those with both the PIK3CA mutation and the MAP3K3 I441M [8]. The gene discussed is MAP3K3; the disease is hemorrhage.